References
- Guo T , FanY, ChenMet al. Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19). JAMA Cardiol. doi:10.1001/jamacardio.2020.1017 (2020) ( Epub ahead of print).
- Shi S , QinM, ShenBet al. Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China. JAMA Cardiol. doi:10.1001/jamacardio.2020.0950 (2020) ( Epub ahead of print).
- Garcia S , AlbaghdadiMS, MerajPMet al. Reduction in ST-segment elevation cardiac catheterization laboratory activations in the united states during COVID-19 pandemic. J. Am. Coll. Cardiol., 75(22), 2871–2872 (2020).
- de Filippo O , D’AscenzoF, AngeliniFet al. Reduced rate of hospital admissions for ACS during Covid-19 outbreak in northern Italy. N. Engl. J. Med. doi:10.1056/NEJMc2009166 (2020) ( Epub ahead of print).
- Solomon MD , McNultyEJ, RanaJSet al. The Covid-19 pandemic and the incidence of acute myocardial infarction. N. Engl. J. Med. doi:10.1056/NEJMc2015630 (2020) ( Epub ahead of print).
- Bakker J . Lives at risk due to 50 per cent drop in heart attack A&E attendances. https://www.bhf.org.uk/what-we-do/news-from-the-bhf/news-archive/2020/april/drop-in-heart-attack-patients-amidst-coronavirus-outbreak
- Rodríguez-Leor O , Cid-ÁlvarezB, OjedaSet al. Impact of the COVID-19 pandemic on interventional cardiology activity in Spain. REC Interv. Cardiol., 2, 82–89 (2020).
- Mattioli AV , NasiM, CocchiC, FarinettiA. COVID 19 outbreak: impact of the quarantine-induced stress on cardiovascular disease risk burden. Future Cardiol. doi:10.2217/fca-2020-0055 (2020) ( Epub ahead of print).
- Januzzi JL . Troponin and BNP use in COVID-19 - American College of Cardiology. https://www.acc.org/latest-in-cardiology/articles/2020/03/18/15/25/troponin-and-bnp-use-in-covid19
- Siripanthong B , NazarianS, MuserDet al. Recognizing COVID-19-related myocarditis: the possible pathophysiology and proposed guideline for diagnosis and management. Heart Rhythm doi:10.1016/j.hrthm.2020.05.001 (2020) ( Epub ahead of print).
- Ueki Y , OtsukaT, WindeckerS, RäberL. ST-elevation myocardial infarction and pulmonary embolism in a patient with COVID-19 acute respiratory distress syndrom. Eur. Heart J., 41(22), 2134 (2020). https://academic.oup.com/eurheartj/advance-article/doi/10.1093/eurheartj/ehaa399/5831090
- Becker RC . COVID-19 update: covid-19-associated coagulopathy. J. Thromb. Thrombolys., 50, 54–67 (2020).
- Kwong JC , SchwartzKL, CampitelliMAet al. Acute myocardial infarction after laboratory-confirmed influenza infection. N. Engl. J. Med., 378(4), 345–353 (2018).
- Wichmann D , SperhakeJ-P, LütgehetmannMet al. Autopsy findings and venous thromboembolism in patients with COVID-19: a prospective cohort study. Ann. Intern. Med. doi:10.7326/M20-2003 (2020) ( Epub ahead of print).
- Naghavi M , WydeP, LitovskySet al. Influenza infection exerts prominent inflammatory and thrombotic effects on the atherosclerotic plaques of apolipoprotein E-deficient mice. Circulation, 107(5), 762–768 (2003).
- Giudicessi JR , NoseworthyPA, FriedmanPA, AckermanMJ. Urgent guidance for navigating and circumventing the QTc-prolonging and torsadogenic potential of possible pharmacotherapies for coronavirus disease 19 (COVID-19). Mayo Clin. Proc., 95(6), 1213–1221 (2020).
- Stefanini GG , MontorfanoM, TrabattoniDet al. ST-elevation myocardial infarction in patients with COVID-19: clinical and angiographic outcomes. Circulation, 141(25), 2113–2116 (2020).
- Buja LM , WolfD, ZhaoBet al. The emerging spectrum of cardiopulmonary pathology of the coronavirus disease 2019 (COVID-19): report of 3 autopsies from Houston, Texas, and review of autopsy findings from other United States cities. Cardiovasc. Pathol., 48, 107233 (2020).
- Varga Z , FlammerAJ, SteigerPet al. Endothelial cell infection and endotheliitis in COVID-19. Lancet, 395(10234), 1417–1418 (2020).
- Thygesen K , AlpertJS, JaffeASet al. Fourth universal definition of myocardial infarction (2018). Circulation, 138(20), e618–e651 (2018).
- Inciardi RM , LupiL, ZacconeGet al. Cardiac involvement in a patient with coronavirus disease 2019 (COVID-19). JAMA Cardiol.doi: https://doi.org/10.1001/jamacardio.2020.1096(2020) ( Epub ahead of print).
- P Caforio AL , PankuweitS, ArbustiniEet al. Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on myocardial and pericardial diseases. Eur. Heart J., 34(33), 2636–2648 (2013).
- Dehghani P , DavidsonLJ, GrinesCLet al. North American COVID-19 ST-segment elevation myocardial infarction (NACMI) registry: Rationale, design, and implications. Am Heart J.https://doi.org/10.1016/j.ahj.2020.05.006 (2020) ( Epub ahead of print).